WebApr 12, 2024 · Shares of Inhibrx, Inc. (NASDAQ:INBX – Get Rating) dropped 7.4% during trading on Monday . The company traded as low as $15.83 and last traded at $15.88. Approximately 54,717 shares were traded during mid-day trading, a decline of 86% from the average daily volume of 400,795 shares. The stock had previously closed at $17.15. Wall […] WebDec 31, 2024 · SAN DIEGO, March 6, 2024 /PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a biopharmaceutical company with four clinical programs in …
INBX - Inhibrx, Inc. Stock Price and Quote - FINVIZ.com
WebFeb 10, 2024 · See the latest Inhibrx Inc Ordinary Shares stock price (NASDAQ:INBX), related news, valuation, dividends and more to help you make your investing decisions. Web2010. Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases. It utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease ... floods in hayward ca
Inhibrx (NASDAQ:INBX) Trading 7.2% Higher - American Banking News
WebMar 10, 2024 · Inhibrx Inc Stock Price History. Inhibrx Inc’s (INBX) price is currently down 10.85% so far this month. During the month of March, Inhibrx Inc’s stock price has reached a high of $24.74 and a low of $20.58. Over the last year, Inhibrx Inc has hit prices as high as $34.72 and as low as $7.67. Year to date, Inhibrx Inc’s stock is down 50.88%. WebMar 24, 2024 · INBX 0.00 0.00% Mar 24, 2024 4:01 p.m. EDT After Hours Vol. 30.33K Price at close $ 19.30 -1.45 -6.99% Mar 24, 2024 4:00 p.m. EDT About Inhibrx Inc. Inhibrx is a clinical-stage biotechnology... Web6 hours ago · Get the latest Stockhead news delivered free to your inbox. For investors, getting access to the right information is critical. Stockhead’s daily newsletters make … great mother megaphone siren head